The oligonucleotide therapeutics field has seen remarkable progress over the last few years
with the approval of the first antisense drug and with promising developments in late stage …

With the first RNA interference (RNAi) drug (ONPATTRO (patisiran)) on the market, we
witness the RNAi therapy field reaching a critical turning point, when further improvements in …

Cationic lipids have become known as one of the most versatile tools for the delivery of
DNA, RNA and many other therapeutic molecules, and are especially attractive because …

In develo** countries, the incidence of colorectal cancer (CRC) is on the rise. The
combination of programmed cell death ligand-1 (PD-L1) siRNA (siPD-L1) and mild …

MicroRNAs are small regulatory noncoding RNAs that regulate various biological processes
associated with neurological disorders, cardiovascular diseases, cancer and viral infection …

Simple Summary Over the last few years, we have witnessed incredible advancements in
anti-tumor drug development. microRNAs, a class of small non-coding RNAs dysregulated …

The rise of infectious diseases as a public health concern has necessitated the development
of rapid and precise diagnostic methods. Imaging techniques like nuclear and optical …

Cancer is a broad term used to describe a group of diseases that have more than 270 types.
Today, due to the suffering of patients from the side effects of existing methods in the …

The flexibility of liposomal carriers does not just simply rely on their capability to encapsulate
various types of therapeutic substances, but also on the large array of components used for …

Drug delivery vectors are widely applied to increase drug efficacy while reducing the side
effects and potential toxicity of a drug. They allow for patient-tailored therapy, dose titration …